Expert Review of Neurotherapeutics

Article	Citations
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system	57
Istradefylline – a first generation adenosine A2A antagonist for the treatment of Parkinson’s disease	55
Diagnosing and managing post-stroke aphasia	40
Sex differences in schizophrenia relevant to clinical care	36
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies	33
Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy	30
Focal cortical dysplasia: an update on diagnosis and treatment	29
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults	27
Nutrition-based interventions for mood disorders	27
Role of environmental factors in multiple sclerosis	27
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	26
Pain in cervical dystonia: mechanisms, assessment and treatment	26
Clinical development of valbenazine for tics associated with Tourette syndrome	25
Nutraceuticals-based therapeutic approach: recent advances to combat pathogenesis of Alzheimer’s disease	24
Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone	22
Sensory stimulation programs in dementia: a systematic review of methods and effectiveness	22
Robot Assisted Ankle Neuro-Rehabilitation: State of the art and Future Challenges	21
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs	21
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies	20
An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management	20
Motor imagery and gait control in Parkinson’s disease: techniques and new perspectives in neurorehabilitation	20
The effect of physical activity with and without cognitive demand on the improvement of executive functions and behavioral symptoms in children with ADHD	19
Speech and language therapy in primary progressive aphasia: a critical review of current practice	19
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia	19
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	19

Reading mind from the eyes in individuals with attention deficit-hyperactivity disorder (ADHD): A meta-analysis	19
Current perspectives on the diagnosis and management of fatigue in multiple sclerosis	19
Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis	18
Acute ischemic stroke management: concepts and controversies.A narrative review	18
Current and emerging treatment modalities for spinocerebellar ataxias	18
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	17
Status epilepticus in pregnancy: a literature review and a protocol proposal	17
Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice	17
Current perspectives on galvanic vestibular stimulation in the treatment of Parkinson’s disease	16
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis	16
Considering patient age when treating multiple sclerosis across the adult lifespan	16
Current challenges in the pathophysiology, diagnosis, and treatment of paroxysmal movement disorders	16
Recent advancements in tension-type headache: a narrative review	16
The efficacy of executive function interventions in children with autism spectrum disorder: a systematic review and meta-analysis	16
Sydenham’s chorea: from pathophysiology to therapeutics	16
Considering hearing loss as a modifiable risk factor for dementia	15
A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders	14
Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis	14
The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics	14
Personalized treatment interventions: nonpharmacological and natural treatment strategies in Alzheimer’s disease	14
The role of a potential biomarker in patients with migraine: review and new insights	14
Outcomes measures in idiopathic intracranial hypertension	14
Real world considerations for newly approved CGRP receptor antagonists in migraine care	14
Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence	14
Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion	13
Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry	13
Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders	13
Nutraceutical induction and mimicry of heme oxygenase activity as a strategy for controlling excitotoxicity in brain trauma and ischemic stroke: focus on oxidative stress	12
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	12
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	12
Evaluating and managing severe headache in the emergency department	12
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients	12
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia	12
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy	12
Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry	11
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters	11
The second phase of brain trauma can be controlled by nutraceuticals that suppress DAMP-mediated microglial activation	11
Present and future of subthalamotomy in the management of Parkinson´s disease: a systematic review	11
Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review	11
Characteristics of a population-based multiple sclerosis cohort treated with disease-modifying drugs in a universal healthcare setting	11
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance	11
A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine	11
Updated review on the link between cortical spreading depression and headache disorders	11
Suicidality and antiepileptic drugs in people with epilepsy: an update	10
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	10
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials	10
Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis	10
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management	10
Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper	10
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	10

Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?	10
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis	10
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives	10
Tumefactive demyelination: updated perspectives on diagnosis and management	10
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication	10
The effect of transcranial magnetic stimulation on the recovery of attention and memory impairment following stroke: a systematic review and meta-analysis	10
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome	10
Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach	9
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice	9
Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis	9
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment	9
Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports	9
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review	9
A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodes	9
Beyond McDonald: updated perspectives on MRI diagnosis of multiple sclerosis	9
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	9
Central vestibular dysfunction: don’t forget vestibular rehabilitation	9
Efficacy and safety of greater occipital nerve block for the treatment of cervicogenic headache: a systematic review	9
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	9
Updated perspectives on awake neurosurgery with cognitive and emotional assessment for patients with low-grade gliomas	9
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures	9
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis	8
The efficacy of rehabilitation in people with Guillain-Barrè syndrome: a systematic review of randomized controlled trials	8
Non-pharmacological treatments for pediatric refractory epilepsies	8
Cognitive function in diabetic persons with peripheral neuropathy: a systematic review and meta-analysis	8
Aripiprazole for the treatment of Tourette syndrome	8
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia	8
Meniere disease subtyping: the direction of diagnosis and treatment in the future	8
Lasmiditan: an additional therapeutic option for the acute treatment of migraine	8
Pathogenesis and Management of Acute Necrotizing Encephalopathy	8
Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study	8
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	8
Developments in the mechanistic understanding and clinical application of deep brain stimulation for Parkinson’s disease	7
Recently available and emerging therapeutic strategies for the acute and prophylactic management of cluster headache: a systematic review and expert opinion	7
Exploring treatments for drooling in children with neurological disorders	7
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders	7
A review of magnetoencephalography use in pediatric epilepsy: an update on best practice	7
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	7
Objective measurement versus clinician-based assessment for Parkinson’s disease	7
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	7
Treating hallucinations in Parkinson’s disease	7
Impact of p-tau181 and p-tau217 levels on enrollment for randomized clinical trials and future use of anti-amyloid and anti-tau drugs	7
Cutting edge approaches to detecting brain mosaicism associated with common focal epilepsies: implications for diagnosis and potential therapies	7
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	7
Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges	7
Managing CLN2 disease: a treatable neurodegenerative condition among other treatable early childhood epilepsies	7
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy	7
Clinical applications of exercise in Parkinson’s disease: what we need to know?	7
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	7
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	7
Acute symptomatic neonatal seizures, brain injury, and long-term outcome: The role of neuroprotective strategies	6
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	6
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	6
Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review	6
Novel therapeutic options for Dravet and Lennox-Gastaut syndrome	6
Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations	6
Hormonal therapies in migraine management: current perspectives on patient selection and risk management	6
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	6
Overcoming clinical challenges of refractory neuropathic pain	6
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	6
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development	6
Early recognition and diagnosis of multiple system atrophy: best practice and emerging concepts	6
Preventing recurrence of postpartum depression by regulating sleep	6
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease	6
Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes	5
Narrative review of the multisensory integration tasks used with older adults: inclusion of multisensory integration tasks into neuropsychological assessment	5
Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review	5
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	5
Stiripentol for the treatment of seizures associated with Dravet syndrome in patients 6 months and older and taking clobazam	5
Progress, development, and challenges in amyotrophic lateral sclerosis clinical trials	5
Considerations when treating high-grade pediatric glioma patients with immunotherapy	5
A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavio	5
Do we need to reconsider the classification of vestibular migraine?	5
Exploring the role of botulinum toxin in critical care	5
Current perspectives on the diagnosis and management of acute transverse myelitis	5
Postoperative pain: a review of emerging therapeutic options	5
Magnetic resonance-guided focused ultrasound for the treatment of tremor	5
Gene and cell therapy and nanomedicine for the treatment of multiple sclerosis: bibliometric analysis and systematic review of clinical outcomes	5
An update on the pharmacotherapeutic options for complex regional pain syndrome	5

Treatment considerations in myasthenia gravis for the pregnant patient	5
The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults	5
Migraine and obesity: what is the real direction of their association?	5
Polyamines serum levels in episodic and chronic migraine	5
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	5
Long-term central nervous system (CNS) consequences of COVID-19 in children	5
Conventional and emerging treatments and controversies in myasthenia gravis	5
Emerging role of artificial intelligence in stroke imaging	4
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	4
Drug profile: galcanezumab for prevention of cluster headache	4
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	4
The comorbidities of epilepsy explained	4
Advances in amyloid-targeting monoclonal antibodies for Alzheimer’s disease: clinical and public health issues	4
Learnings in developmental and epileptic encephalopathies: what do we know?	4
Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: a pragmatic review	4
Telerehabilitation in neurorehabilitation: has it passed the COVID test?	4
Tackling seizures in patients with Alzheimer’s disease	4
Neuroimaging and genetic characteristics of malformation of cortical development due to mTOR pathway dysregulation: clues for the epileptogenic lesions and indications for epilepsy surgery	4
Tailoring the therapeutic interventions for behavioral and psychological symptoms of dementia	4
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	4
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	4
Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?	4
Developing precision treatments for epilepsy using patient and animal models	4
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases	4
Tackling the neurological manifestations in Wilson’s disease – currently available treatment options	4
Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts	4
Where Art Thou O treatment for diabetic neuropathy: the sequel	4
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	4
EEG in neonatal seizures: where to look and what to see	4
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	4
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	3
Advances in the treatment and management of frontotemporal dementia	3
Evaluating lumateperone for its use in treating depressive episodes associated with bipolar I or II disorder in adults	3
Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients	3
Immunopsychiatry: an update on autoimmune encephalitis for neuropsychiatrists	3
Advancements in neuroactive peptides in seizures	3
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	3
Viruses - a major cause of amyloid deposition in the brain	3
Posterior cortical atrophy: clinical, neuroimaging, and neuropathological features	3
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	3
Temporal distribution of emergency room visits in patients with migraine and other headaches	3
Nanomaterials in neuromodulation: what is the potential?	3
Aducanumab and adenoviral COVID-19 vaccines: increased cerebral hemorrhage risk?	3
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	3
Profiling lecanemab as a treatment option for Alzheimer’s disease	3
A novel treatment option for intrajejunal levodopa administration	3
Can regular physical exercise be a treatment for panic disorder? A systematic review	3
The role of sex and pregnancy in multiple sclerosis: what do we know and what should we do?	3
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	3
Spinal automaticity of movement control and its role in recovering function after spinal injury	3
Neurosarcoidosis: an update on diagnosis and therapy	3
Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials	3
An updated review on prediction and preventive treatment of post-stroke depression	3
An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia	3
Cortical hyperexcitability and plasticity in Alzheimer’s disease: developments in understanding and management	3
Updated review of rescue treatments for seizure clusters and prolonged seizures	3
Understanding and managing the impact of the COVID-19 pandemic and lockdown on patients with epilepsy	3
Food for thought: the emerging role of a ketogenic diet in Alzheimer’s disease management	3
Identifying risk factors for chronic postsurgical pain and preventive measures: a comprehensive update	3
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	3
Management of status epilepticus in patients with liver or kidney disease: a narrative review	3
Insights into headache 2022	3